At the time of writing, Privia Health Group Inc [PRVA] stock is trading at $23.96, up 1.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRVA shares have gain 4.86% over the last week, with a monthly amount glided 1.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Privia Health Group Inc [NASDAQ: PRVA] stock has seen the most recent analyst activity on January 09, 2026, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $31. Previously, BMO Capital Markets started tracking the stock with Outperform rating on November 13, 2025, and set its price target to $30. On January 10, 2025, Needham initiated with a Buy rating and assigned a price target of $25 on the stock. Macquarie started tracking the stock assigning an Outperform rating. KeyBanc Capital Markets initiated its recommendation with an Overweight and recommended $23 as its price target on October 11, 2024. Robert W. Baird started tracking with an Outperform rating for this stock on May 30, 2024, and assigned it a price target of $23. In a note dated April 22, 2024, Citigroup initiated a Buy rating and provided a target price of $25 on this stock.
For the past year, the stock price of Privia Health Group Inc fluctuated between $18.77 and $26.51. Currently, Wall Street analysts expect the stock to reach $29.6 within the next 12 months. Privia Health Group Inc [NASDAQ: PRVA] shares were valued at $23.96 at the most recent close of the market. An investor can expect a potential return of 23.54% based on the average PRVA price forecast.
Analyzing the PRVA fundamentals
According to Privia Health Group Inc [NASDAQ:PRVA], the company’s sales were 2.04B for trailing twelve months, which represents an 32.54% jump. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Privia Health Group Inc [NASDAQ:PRVA] has a current ratio of 1.67. In addition, the Quick Ratio stands at 1.67 and the Cash Ratio stands at 0.76. Considering the valuation of this stock, the price to sales ratio is 1.44, the price to book ratio is 4.15 and price to earnings (TTM) ratio is 168.73.
Transactions by insiders
Recent insider trading involved Morris Matthew Shawn, Director, that happened on Dec 12 ’25 when 13647.0 shares were sold. EVP & Chief Financial Officer, Mountcastle David completed a deal on Dec 12 ’25 to sell 23887.0 shares. Meanwhile, Director Matthew Shawn Morris bought 0.83 million shares on Dec 12 ’25.
